Dr. Adedeji served as VP and Head of Drug Safety and PV at BeyondSprings Pharma, an oncology based drug development company headquartered in NY before joining Fore. He oversaw all safety related activities in sponsored trials and investigator initiated trials geared towards NDA submission of a product with multiple indications and submission in two global territories. Prior to that, he was the Executive Medical Director and Head of Safety at Purdue Pharma, where he lead the initiative of safety reporting of over 35,000 cases for the ongoing opioid multi-district litigation. During his 19+ years in Pharma, he has worked with diverse therapeutic areas including, CNS, Social medicine, women’s health, pain and inflammation and oncology. Yemi received his medical degree from Spartan Health Science University and trained at Howard University, Washington DC to be an OBGYN.
